Jump to main content
Jump to site search

Issue 29, 2017
Previous Article Next Article

Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose

Author affiliations

Abstract

Fullerene-based nanoparticles have been the subject of vital interest due to their unique properties and potential application in many areas, including medicine. Here we explore their characteristics that could make them prospective leads for known disease-related proteins. High-throughput virtual screening supported by comprehensive multi-software protein–ligand docking simulation and cheminformatics approaches has been applied in investigation of interactions of 1117 proteins with a 169 fullerene nanoparticles decorated with different small molecules. Moreover, obtained docking results were confirmed by the series of unrestricted all-atom molecular dynamics (MD) simulations. Hydrophobicity of fullerene core along with hydrophilic interaction of side chains plays a key role in binding with the studied proteins. We identified a series of nanoparticles that can lead to development of robust drugs for target proteins and another series that can behave as a highly toxic agent. The structure–activity relationship analysis revealed two significant molecular properties responsible for the binding score values. The application of carefully selected computational techniques and described outcome of the study facilitate development of functional fullerene nanoparticles for drug-like and drug delivery applications.

Graphical abstract: Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose

Back to tab navigation

Supplementary files

Publication details

The article was received on 02 Feb 2017, accepted on 28 Jun 2017 and first published on 29 Jun 2017


Article type: Paper
DOI: 10.1039/C7NR00770A
Citation: Nanoscale, 2017,9, 10263-10276
  •   Request permissions

    Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose

    L. Ahmed, B. Rasulev, S. Kar, P. Krupa, M. A. Mozolewska and J. Leszczynski, Nanoscale, 2017, 9, 10263
    DOI: 10.1039/C7NR00770A

Search articles by author

Spotlight

Advertisements